Vicarious Surgical
RBOT
RBOT was delisted on the 2nd of March, 2026.
79 hedge funds and large institutions have $116M invested in Vicarious Surgical in 2022 Q2 according to their latest regulatory filings, with 32 funds opening new positions, 22 increasing their positions, 13 reducing their positions, and 13 closing their positions.
1,063% more call options, than puts
Call options by funds: $5.62M | Put options by funds: $483K
146% more first-time investments, than exits
New positions opened: 32 | Existing positions closed: 13
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
69% more repeat investments, than reductions
Existing positions increased: 22 | Existing positions reduced: 13
30% more funds holding
Funds holding: 61 → 79 (+18)
0.17% more ownership
Funds ownership: 1.13% → 1.3% (+0.17%)
32% less capital invested
Capital invested by funds: $171M → $116M (-$55.2M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$8.05M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$2.52M |
| 3 |
State Street
Boston,
Massachusetts
|
+$2.45M |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$1.83M |
| 5 |
Northern Trust
Chicago,
Illinois
|
+$1.5M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$694K |
| 2 |
ECM
ExodusPoint Capital Management
New York
|
-$618K |
| 3 |
BFS
Bradley Foster & Sargent
Hartford,
Connecticut
|
-$281K |
| 4 |
Legal & General Group
London,
United Kingdom
|
-$258K |
| 5 |
Jane Street
New York
|
-$222K |
RBOT Hedge Fund Activity: Q2 2022 in Review
79 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in Vicarious Surgical (RBOT) for Q2 2022, worth a combined $116M — down 32% from $171M a quarter earlier.
Buyers outnumbered sellers: 32 funds opened new RBOT positions and 13 closed out — a net gain of 19 holders — while 22 added to existing stakes and 13 trimmed.
The largest buyer was BlackRock, adding an estimated $8.05M. The largest seller was Millennium Management, exiting entirely with an estimated $694K sold.
- 79 institutional investors held Vicarious Surgical (RBOT) as of Q2 2022, up from 61 in Q1 2022.
- Funds reported $116M of Vicarious Surgical stock for Q2 2022, down 32% quarter-over-quarter.
- 32 funds opened new Vicarious Surgical positions in Q2 2022 and 13 closed out, a net change of +19 holders.
- The largest Vicarious Surgical buyer in Q2 2022 was BlackRock, an estimated $8.05M added.
- The largest Vicarious Surgical seller in Q2 2022 was Millennium Management, an estimated $694K sold.
Based on aggregated 13F filings for Q2 2022.